in the news

Newsroom
No items found.
Showing
1–25
of 100
Sort
Sep 19, 2023
Award
[ExtERNAL]
PharmaVoice 100 Stand-out Execs: Michelle Werner
Sep 14, 2023
Article
[ExtERNAL]
In Vivo: Exploring Alltrna’s Rare Disease Platform
Sep 6, 2023
Article
[ExtERNAL]
The Scientist: The Origins and Recent Promise of Nonsense Suppressor tRNAs
Aug 9, 2023
Article
[ExtERNAL]
MedCity News: Alltrna Unveils $109M to Make tRNA a Universal Therapy for Genetic Diseases
Aug 9, 2023
Article
[ExtERNAL]
Boston Business Journal: Flagship-backed RNA startup company raises $109M
Aug 9, 2023
Article
[ExtERNAL]
BioPharma Dive: Alltrna raises $109M for ‘transfer RNA’ drug vision
Aug 9, 2023
Article
[ExtERNAL]
MedCity News: Alltrna Unveils $109M to Make tRNA a Universal Therapy for Genetic Diseases
Aug 9, 2023
Article
[ExtERNAL]
Endpoints: Flagship startup Alltrna raises $109M for tRNA therapies that restore missing proteins
Aug 9, 2023
Article
[ExtERNAL]
BioCentury: Alltrna raises $109M for unified approach to stop codon diseases
Aug 9, 2023
Article
[ExtERNAL]
Fierce Biotech: Flagship's Alltrna collects $109M as it passes go to Stop Codon Disease
Aug 3, 2023
Video
[ExtERNAL]
VibeCast: Michelle C. Werner on Alltrna's tRNA Medicine for Stop Codon Disease | Episode 22
May 23, 2023
Article
[ExtERNAL]
GEN Edge: No-nonsense - Alltrna Touts tRNA Therapeutics to Treat Thousands of Diseases
Mar 1, 2023
Video
[ExtERNAL]
NYSE The Cure(ious): The Future of Health
Feb 22, 2023
Podcast
[ExtERNAL]
PharmaVoice Woman of the Week Podcast: Alltrna’s Michelle Werner
Nov 4, 2022
Award
[ExtERNAL]
C&EN: 10 Start-Ups to Watch for 2022
Jul 28, 2022
Article
[ExtERNAL]
Business Insider: Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs